Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants - Takeaways - MDSpire

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

  • By

  • J R Passweg

  • H Baldomero

  • P Bader

  • C Bonini

  • S Cesaro

  • P Dreger

  • R F Duarte

  • C Dufour

  • J H F Falkenburg

  • D Farge-Bancel

  • A Gennery

  • N Kröger

  • F Lanza

  • A Nagler

  • A Sureda

  • M Mohty

  • February 2, 2015

  • 0 min

Share

  • 1

    In 2013, a total of 34,809 patients received their first hematopoietic stem cell transplants in Europe, marking a 3.4% increase from the previous year.

  • 2

    The survey indicated a rise in the use of haploidentical donors for allogeneic HSCT, while the number of cord blood transplants decreased.

  • 3

    Of the 658 reporting teams, 406 performed both allogeneic and autologous transplants, highlighting a diverse range of transplant capabilities.

  • 4

    Allogeneic HSCT accounted for 43% of first transplants in 2013, with autologous HSCT making up the remaining 57%.

  • 5

    The survey's standardized structure over 20 years allows for effective monitoring of trends and changes in hematopoietic SCT practices across Europe.

Original Source(s)

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

  • by J R Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, R F Duarte, C Dufour, J H F Falkenburg, D Farge-Bancel, A Gennery, N Kröger, F Lanza, A Nagler, A Sureda, M Mohty

  • February 2, 2015

Related Content

Refining CAR-NK Design

Preclinical findings suggest that receptor design and timed kinase inhibition could help strengthen next-generation cell therapies.

  • March 4, 2026

  • 2 min
Case Report: Extranodal marginal zone B-cell lymphoma in the lateral ventricle: literature review

Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas